Please Wait.....
Report
Ophthalmic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Report I 2023-06-14 I 138 Pages I IMARC Group
The global ophthalmic drugs market size reached US$ 42.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 59.1 Billion by 2028, exhibiting a growth rate (CAGR) of 5.3% during 2023-2028.
Ophthalmic drugs are medications that are specially designed and administered for the treatment of various eye-related disorders, including color blindness, diabetic macular edema, cytomegalovirus (CMV), and age-related macular degeneration (AMD). These medications can be delivered in the form of an emulsion, ointment, aqueous gels, dendrimers, nanosuspensions, or contact lenses. Ophthalmic drugs are manufactured from neomycin, antibiotics, bacitracin, and polymyxin that aid in mitigating the growth of bacterial infection in the eye. At present, they are commercially available in solid, liquid, and semi-solid formulation types.
Ophthalmic Drugs Market Trends:
The increasing prevalence of various eye-related disorders, such as visual impairment, glaucoma, and color blindness, especially amongst the rising geriatric population, is primarily driving the ophthalmic drugs market growth. In line with this, the rising awareness regarding the anti-inflammatory properties of the drug is further facilitating their demand to treat scleritis, cystoid macular edema, and uveitis disorders. Moreover, the extensive fundings and favorable initiatives being undertaken by the governments of several countries to promote the production of effective ophthalmic drugs with novel formulations and combinations are also supporting the market growth. Besides this, significant technological advancements, including the introduction of gene-drug therapies for diagnosing and treating hereditary ophthalmic, neurovascular retinal, and retinoblastoma disorders, are acting as another growth-inducing factors. Additionally, the easy availability of ophthalmic drugs in eye solutions, drops, capsules, tablets, gels, and ointments forms across several online and offline distribution channels is contributing to the market growth. Other factors, such as significant expansion in the pharmaceutical industry, along with rising research and development (R&D) activities to introduce cost-effective ocular drug delivery systems (ODDS), are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global ophthalmic drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, drug class, indication, dosage form and distribution channel.
Breakup by Type:
Prescription Drugs
Over-the-counter Drugs
Breakup by Drug Class:
Anti-glaucoma
Anti-infection
Anti-inflammation
Anti-allergy
Others
Breakup by Indication:
Dry Eye
Glaucoma
Infection/Inflammation/Allergy
Retinal Disorders
Others
Breakup by Dosage Form:
Liquid Ophthalmic Drug Forms
Solid Ophthalmic Drug Forms
Semisolid Ophthalmic Drug Forms
Multicompartment Drug Delivery Systems
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Drug Stores
Online Pharmacies
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Aerie Pharmaceuticals Inc., Akorn Inc., Alcon, Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd. and Sun Pharmaceutical Industries Ltd.
Key Questions Answered in This Report:
How has the global ophthalmic drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global ophthalmic drugs market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the dosage form?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global ophthalmic drugs market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Ophthalmic Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Prescription Drugs
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Over-the-counter Drugs
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Class
7.1 Anti-glaucoma
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Anti-infection
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Anti-inflammation
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Anti-allergy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Indication
8.1 Dry Eye
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Glaucoma
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Infection/Inflammation/Allergy
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Retinal Disorders
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Dosage Form
9.1 Liquid Ophthalmic Drug Forms
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Solid Ophthalmic Drug Forms
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Semisolid Ophthalmic Drug Forms
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Multicompartment Drug Delivery Systems
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Drug Stores
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Online Pharmacies
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 AbbVie Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Aerie Pharmaceuticals Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.3 Akorn Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 Alcon
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.5 Bausch Health Companies Inc.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 Bayer AG
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 F. Hoffmann-La Roche AG
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 SWOT Analysis
16.3.8 Johnson & Johnson
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Merck & Co. Inc.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Novartis AG
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Regeneron Pharmaceuticals Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
16.3.12 Santen Pharmaceutical Co. Ltd.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.13 Sun Pharmaceutical Industries Ltd.
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
Figure 1: Global: Ophthalmic Drugs Market: Major Drivers and Challenges
Figure 2: Global: Ophthalmic Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Ophthalmic Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Ophthalmic Drugs Market: Breakup by Type (in %), 2022
Figure 5: Global: Ophthalmic Drugs Market: Breakup by Drug Class (in %), 2022
Figure 6: Global: Ophthalmic Drugs Market: Breakup by Indication (in %), 2022
Figure 7: Global: Ophthalmic Drugs Market: Breakup by Dosage Form (in %), 2022
Figure 8: Global: Ophthalmic Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 9: Global: Ophthalmic Drugs Market: Breakup by Region (in %), 2022
Figure 10: Global: Ophthalmic Drugs (Prescription Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Ophthalmic Drugs (Prescription Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Ophthalmic Drugs (Over-the-counter Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Ophthalmic Drugs (Over-the-counter Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Ophthalmic Drugs (Anti-glaucoma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Ophthalmic Drugs (Anti-glaucoma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Ophthalmic Drugs (Anti-infection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Ophthalmic Drugs (Anti-infection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Ophthalmic Drugs (Anti-inflammation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Ophthalmic Drugs (Anti-inflammation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Ophthalmic Drugs (Anti-allergy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Ophthalmic Drugs (Anti-allergy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Ophthalmic Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Ophthalmic Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Ophthalmic Drugs (Dry Eye) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Ophthalmic Drugs (Dry Eye) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Ophthalmic Drugs (Glaucoma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Ophthalmic Drugs (Glaucoma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Ophthalmic Drugs (Infection/Inflammation/Allergy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Ophthalmic Drugs (Infection/Inflammation/Allergy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Ophthalmic Drugs (Retinal Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Ophthalmic Drugs (Retinal Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Ophthalmic Drugs (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Ophthalmic Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Ophthalmic Drugs (Liquid Ophthalmic Drug Forms) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Ophthalmic Drugs (Liquid Ophthalmic Drug Forms) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Ophthalmic Drugs (Solid Ophthalmic Drug Forms) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Ophthalmic Drugs (Solid Ophthalmic Drug Forms) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Ophthalmic Drugs (Semisolid Ophthalmic Drug Forms) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Ophthalmic Drugs (Semisolid Ophthalmic Drug Forms) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Global: Ophthalmic Drugs (Multicompartment Drug Delivery Systems) Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Global: Ophthalmic Drugs (Multicompartment Drug Delivery Systems) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Global: Ophthalmic Drugs (Other Dosage Forms) Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Global: Ophthalmic Drugs (Other Dosage Forms) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Global: Ophthalmic Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Global: Ophthalmic Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Global: Ophthalmic Drugs (Drug Stores) Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Global: Ophthalmic Drugs (Drug Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Global: Ophthalmic Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Global: Ophthalmic Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Global: Ophthalmic Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Global: Ophthalmic Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: North America: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: North America: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: United States: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: United States: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Canada: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Canada: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Asia-Pacific: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Asia-Pacific: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: China: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: China: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Japan: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Japan: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: India: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: India: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: South Korea: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: South Korea: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Australia: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Australia: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Indonesia: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Indonesia: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Europe: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Europe: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Germany: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Germany: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: France: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: France: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: United Kingdom: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: United Kingdom: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Italy: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Italy: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Spain: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Spain: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Russia: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Russia: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Others: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 89: Others: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Latin America: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 91: Latin America: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Brazil: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 93: Brazil: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 94: Mexico: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 95: Mexico: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 96: Others: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 97: Others: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 98: Middle East and Africa: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 99: Middle East and Africa: Ophthalmic Drugs Market: Breakup by Country (in %), 2022
Figure 100: Middle East and Africa: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 101: Global: Ophthalmic Drugs Industry: SWOT Analysis
Figure 102: Global: Ophthalmic Drugs Industry: Value Chain Analysis
Figure 103: Global: Ophthalmic Drugs Industry: Porter's Five Forces Analysis
Table 1: Global: Ophthalmic Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Ophthalmic Drugs Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Ophthalmic Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
Table 4: Global: Ophthalmic Drugs Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 5: Global: Ophthalmic Drugs Market Forecast: Breakup by Dosage Form (in Million US$), 2023-2028
Table 6: Global: Ophthalmic Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 7: Global: Ophthalmic Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Ophthalmic Drugs Market: Competitive Structure
Table 9: Global: Ophthalmic Drugs Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security